DAVID BAR-OR, M.D.; KENNETH KULIG, M.D.; JOHN A MARX, M.D.; PETER ROSEN, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: Verapmil has been recently approved by the FDA for the treatment of supraventricular tachycardia. Adverse reactions have occurred when verapamil has been used with various other drugs such as intravenous beta blockers (1), and calcium and vitamin D (2). Compatibility of verapamil with other additives has been reported (3). We report the precipitation of verapamil in an intravenous bicarbonate solution not previously described.
A patient had high-voltage shock and presented to the emergency department in stable condition, but with new onset of atrial fibrillation. The ventricular rate was 150 min. An intravenous line of 0.45 normal saline
BAR-OR D, KULIG K, MARX JA, et al. Precipitation of Verapamil. Ann Intern Med. 1982;97:619. doi: 10.7326/0003-4819-97-4-619_1
Download citation file:
Published: Ann Intern Med. 1982;97(4):619.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use